Status:

COMPLETED

Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration

Lead Sponsor:

Aarhus University Hospital

Conditions:

Insulin Sensitivity

Eligibility:

MALE

18-30 years

Phase:

NA

Brief Summary

Recently EPO receptors have been found in human muscle tissue, but what is still not known is the physiological role of these receptors. In this study the researchers want to investigate if there is a...

Detailed Description

Recently EPO receptors have been found in human muscle tissue, but what is still not known is what the physiological role of these receptors are. It has previously been shown that Growth Hormone media...

Eligibility Criteria

Inclusion

  • Healthy persons
  • Between 18 and 30 years
  • Normal weight (BMI: 18-25)

Exclusion

  • Severe heart disease (NYHA 3)
  • Uncontrolled hypertension
  • Previous cerebrovascular disease
  • Proliferative retinopathy
  • Diabetes
  • Musculo-skeletal diseases

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00793767

Start Date

January 1 2009

Last Update

May 29 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medicinsk forsknings laboratorium

Århus C, Denmark, 8000